Mental Health Newswire
201 - Research and Markets: Cognitive Approaches to the Assessment of Sexual Interest in Sexual Offenders
DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets . Index. For more information visit http://www.researchandmarkets.com/research/8947f1/cognitive_approach
202 - ICF International Awarded Over $17M Task Order to Support Substance Abuse and Mental Health Services Administration’s Underage Drinking Prevention Initiatives
FAIRFAX, Va.-(Business Wire)-September 22, 2009 - Macro International (ICF Macro), a subsidiary of ICF International (NASDAQ:ICFI), was recently awarded a new task order under its U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA...
203 - Get Out of the Discipline Trap! Create a New Family Culture of Discipline with The Family Coach Method
PHOENIX-(Business Wire)-September 22, 2009 - Parents are tired and frustrated by current methods of discipline and punishment offered in books and media today. Parents understand that they are living in “The Discipline Trap,” believing that discipline is something we do to our children rather...
204 - Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Psychiatric Solutions, Inc.
SAN DIEGO-(Business Wire)-September 21, 2009 - Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) has more information about the firm.
205 - Research and Markets: Ethics for Psychologists, 2nd Edition Will Prove an Invaluable Resource to Those Seeking a Broad, Cross-National Ethical Perspective
DUBLIN-(Business Wire)-September 21, 2009 - Research and Markets Key Topics Covered: Preface. Acknowledgements. Part I: Conceptual Issues in Ethics. Part II: Principles and Codes. Part III: Practical Issues in Ethics. Part IV: Decision-Making Issues. Appendix I: The European Federation of...
206 - Antigenics Announces Expansion of Its QS-21 License Agreement
LEXINGTON, Mass.-(Business Wire)-September 21, 2009 - Antigenics Inc. (NASDAQ: AGEN) today announced that the company has signed an amended and restated license agreement for the use of the QS-21 adjuvant in a vaccine under development by JANSSEN Alzheimer Immunotherapy, a company which has acquired...
207 - Research and Markets: Handbook of Psychology of Investigative Interviewing: Current Developments and Future Directions
DUBLIN-(Business Wire)-September 21, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Handbook of Psychology of Investigative Interviewing: Current Developments and Future Directions" to their offering. With chapters written by internationally acclaimed...
208 - In a Tough Economy, Bioscience Research, LLC Helps Eligible Westchester County Residents Access Depression Care at no Cost
MOUNT KISCO, N.Y.-(Business Wire)-September 21, 2009 - Psychiatrists at Bioscience Research, LLC, understand the mental health burden that can accompany unemployment and the day-to-day stress of looking for a new job or worrying about losing an existing job. In response to the area’s increased...
209 - ICF International Awarded over $7M Contract by the Substance Abuse and Mental Health Services Administration
FAIRFAX, Va.-(Business Wire)-September 21, 2009 - ICF International (NASDAQ:ICFI) was awarded a new, five-year contract valued at more than $7 million with the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA). Under this task order...
210 - Hythiam Receives NASDAQ Notification Regarding Bid Price; Grace Period Granted Through March 15, 2010
LOS ANGELES-(Business Wire)-September 18, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that on September 15, 2009, the Company received a letter from The NASDAQ Stock Market indicating that because the bid price of the Company’s common stock had closed below the minimum $1.00 per share...
211 - Research and Markets: This Essential and Comprehensive Report on International Neurology is Now Available
DUBLIN-(Business Wire)-September 18, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "International Neurology" to their offering. A truly global textbook for neurological practice Neurological disease varies in its presentations and pathology throughout...
212 - Hythiam Raises Approximately $7 Million in Registered Direct Offering
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering, representing...
213 - American Claims Evaluation, Inc. Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule
JERICHO, N.Y.-(Business Wire)-September 17, 2009 - American Claims Evaluation, Inc. (Nasdaq: AMCE) (the “Company”) today announced that on September 15, 2009, the Company received a deficiency letter from The Nasdaq Stock Market indicating that the closing bid price of its common stock had...
214 - Hythiam Enters into Agreement with Ford Motor Company for Catasys Integrated Substance Dependence Solution
LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that the Company has entered into a three year agreement with Ford® Motor Company to provide the Catasys® integrated substance dependence solution to Ford’s hourly employees in Michigan enrolled in the...
215 - PHC Announces Fiscal 2009 Fourth Quarter and Year-end Results and Continued Profitability
PEABODY, Mass.-(Business Wire)-September 17, 2009 - PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE Amex: PHC), a leading provider of inpatient and outpatient behavioral health services, reported financial results for the company's fourth fiscal quarter and year ended June 30, 2009. The results...
216 - Success for the European Federation of Neurological Associations ‘Good Life’ symposium
LONDON-(Business Wire)-September 16, 2009 - The European Federation of Neurological Associations (EFNA) celebrated the success of its ‘Good Life’ symposium at the European Federation of Neurological Societies (EFNS) conference in Florence last weekend. More than 300 guests attended the session...
217 - Devereux Pennsylvania to Host Masquerade Gala Honoring Trustee Lisa Yang
VILLANOVA, Pa.-(Business Wire)-September 16, 2009 - Devereux Pennsylvania will host its 11th Annual Gala, A Mystery and Magic Black-Tie Affair, at the Park Hyatt Philadelphia at the Bellevue, October 3rd at 6:30 p.m. Devereux trustee and parent Lisa Yang, Rosemont, PA, will be honored at the event...
218 - PerkinElmer Purchases GE Healthcare’s Catalog Radiochemicals, SPA Reagents and Cytostar-T Plate Assets
WALTHAM, Mass.-(Business Wire)-September 16, 2009 - PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced that it has purchased the assets of GE Healthcare’s 3H and 14C Catalog Radiochemicals, Scintillation Proximity Assay...
219 - LifeScience Alley® Crossroad Series Fall Symposium to Explore Triggers behind Material Changes in Individual Health Behavior
MINNEAPOLIS-(Business Wire)-September 15, 2009 - LifeScience Alley® announced today that its fall Crossroad Series symposium, “Creating a Culture of Health: Helping People Stay Well”, will be held on Sept. 25, 2009 at Travelers in Saint Paul, Minn. The symposium will look at what drives...
220 - Emeritus to Participate in Blackstone Offer to Acquire 148 Senior Living Communities
SEATTLE-(Business Wire)-September 15, 2009 - Emeritus Corporation (NYSE: ESC), a national provider of assisted living and Alzheimer’s care services to seniors, today announced that it has been selected by Blackstone Real Estate Advisors (“BREA”) as manager in conjunction with BREA’s...
221 - Research and Markets: Psychotic Disorders Therapy Area Pipeline Report - Detailed Information on the Psychotic Disorders Drug Pipeline
DUBLIN-(Business Wire)-September 15, 2009 - Research and Markets has announced the addition of the "Psychotic Disorders Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Psychotic Disorders Therapy Area Pipeline Report contains detailed information on the psychotic...
222 - Research and Markets: Psychiatry Board Review Course - an in-Depth, Case-Based Review, Designed to Help Psychiatrists and Psychiatrists-in-Training
DUBLIN-(Business Wire)-September 15, 2009 - Research and Markets program, which is mandated by the ABMS as a necessary component of maintenance of certification. Date of Original Release: July 1, 2009 Date of Credit Termination: July 31, 2012 CME credit is obtained upon successful completion of a...
223 - PHC, Inc. To Announce 2009 Fiscal Fourth Quarter and Year-end Results on Thursday, September 17th
PEABODY, Mass.-(Business Wire)-September 15, 2009 - PHC, Inc., d/b/a Pioneer Behavioral Health (NYSE AMEX: PHC), a leading provider of inpatient and outpatient behavioral health services, announced today that it will release fourth quarter and 2009 fiscal year end results on Thursday, September 17th...
224 - Research and Markets: Addiction Treatment Homework Planner, 4th Edition
DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets . SECTION VII: Borderline Traits. SECTION VIII: Childhood Trauma. SECTION IX: Chronic Pain. SECTION X: Dangerousness/Lethality. SECTION XI: Dependent Traits. SECTION XII: Depression. SECTION XIII: Eating Disorders. SECTION XIV...
225 - Neurologix to Showcase Novel Brain and CNS Disease Gene Therapies at BioPharm America
FORT LEE, N.J.-(Business Wire)-September 14, 2009 - Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that the company will showcase its novel gene transfer approach to...
226 - Research and Markets: A Handbook of Neurological Investigations in Children
DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets 20 years ago. This new book, while closely following the highly successful approach of the earlier title, is thoroughly up to date, with fresh material, new case vignettes, and additional investigations covered. Key Topics Covered...
227 - ExonHit Presents Promising First Patient Results for EHT 0202, Its Alzheimer’s Candidate Drug
PARIS-(Business Wire)-September 14, 2009 - Regulatory News: ExonHit Therapeutics (Paris:ALEHT): Top-line Phase IIa clinical data released today demonstrate that EHT 0202, ExonHit’s lead candidate for the treatment of Alzheimer’s disease, is safe and generally well tolerated in patients and...
228 - Medtronic Recognizes Recipient of World Journal of Surgery ''Best of 2008'' Award
MINNEAPOLIS-(Business Wire)-September 11, 2009 - Medtronic (NYSE: MDT) today recognized Henning Dralle, M.D., Professor at the University of Halle-Wittenberg in Halle, Germany, who received the World Journal of Surgery award for Best Paper of 2008. Professor Dralle received the award as lead...
229 - Little City Foundation Answers President’s Call to Join in ‘National Day of Service and Remembrance’ by Raising Awareness and Importance of Service to Nation’s Most Vulnerable Citizens
PALATINE, Ill.-(Business Wire)-September 11, 2009 - Little City Foundation today participates in the federally recognized September 11 National Day of Service and Remembrance by calling all its volunteers to raise funds and awareness through its Smiles Tag Campaign for hundreds of children and...
230 - Aspect Medical Systems Announces Publication of BRITE-MD Trial Results in Psychiatry Research
NORWOOD, Mass.-(Business Wire)-September 11, 2009 - Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that two companion articles highlighting results from the BRITE-MD (Biomarkers for Rapid Identification of Treatment Effectiveness trial in Major Depression) were published in the...
231 - Cindy McCain Helps Raise National Awareness to Conquer Migraine
PHILADELPHIA-(Business Wire)-September 10, 2009 - Cindy McCain, wife of U.S. Senator John McCain, today announced she would work to raise awareness of migraine among the public and health professionals and pledged to take her message to leaders in Washington to increase funding for research into...
232 - United BioSource Corporation Announces Acquisition of Cognitive Drug Research, Ltd. to Advance Services in Cognitive Testing in Clinical Research
BETHESDA, Md.-(Business Wire)-September 10, 2009 - United BioSource Corporation (UBC) today announced the acquisition of Cognitive Drug Research, Ltd. (CDR), the leader in computerized cognitive testing for clinical trials. The CDR System is the most widely used computerized cognitive testing system...
233 - Research and Markets: Memory Impairment Therapy Area Pipeline Report
DUBLIN-(Business Wire)-September 10, 2009 - Research and Markets has announced the addition of the "Memory Impairment Therapy Area Pipeline Report" report to their offering. Life Science Analytics, Memory Impairment Therapy Area Pipeline Report contains detailed information on the memory...
234 - Data to be Presented on Multiple Targacept NNR Therapeutics at Society for Neuroscience Satellite Symposium
WINSTON-SALEM, N.C.-(Business Wire)-September 10, 2009 - Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an...
235 - Avid Radiopharmaceuticals Expands Management Team to Support Alzheimer’s and Parkinson’s Disease Imaging Programs
PHILADELPHIA-(Business Wire)-September 9, 2009 - Avid Radiopharmaceuticals, Inc. today announced the appointment of Christopher J. Bunting as the company’s Vice President, Marketing and Sales. In this role, Mr. Bunting will be responsible for the commercialization of 18F-AV-45 (AV-45), the most...
236 - Hythiam Presentation at Rodman and Renshaw Annual Global Investment Conference to Be Simultaneously Webcast
LOS ANGELES-(Business Wire)-September 8, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that Terren Peizer, Chairman and Chief Executive Officer of Hythiam, will be presenting at the Rodman and Renshaw Annual Global Investment Conference on Wednesday, September 9, 2009 at 12:30 p.m. EDT. The...
237 - Research and Markets: Disease and Therapy Review: Major Depressive Disorder - Detailed Information on the Depression Market
DUBLIN-(Business Wire)-September 7, 2009 - Research and Markets has announced the addition of the "Disease and Therapy Review:Major Depressive Disorder" report to their offering. The Major Depressive Disorder Disease and Therapy Review provides an overview of the disease and related conditions, with...
238 - The European Federation of Neurological Associations Celebrates ‘The Good Life’
LONDON-(Business Wire)-September 7, 2009 - The European Federation of Neurological Associations (EFNA) and European Federation of Neurological Societies (EFNS) will be celebrating ‘The Good Life’ at the 13th EFNS Congress in September, to focus on what people living with neurological disorders...
239 - Toward a Common Morality: Center for Neurotechnology Studies & Nour Foundation Host Conference at United Nations September 11, 2009
ARLINGTON, Va.-(Business Wire)-September 4, 2009 - Discoveries in neuroscience and neurotechnology have provided a unique window through which we can glance into the intricate workings of the human brain. Yet, as these technologies have evolved, they have also highlighted the fundamental limitations...
240 - Leonard J. Brandt, William E. Bunney, Jr., M.D., William Murray, Mordechay Yekutiel, Andy Goren, David W. Mazepink Announce Voting Results regarding Election of Directors at CNS Response, Inc. Special Stockholder Meeting Today
IRVINE, Calif.-(Business Wire)-September 4, 2009 - Leonard J. Brandt, William E. Bunney, Jr., M.D., William Murray, Mordechay Yekutiel, Andy Goren, David W. Mazepink today announced that they were elected to the Board of CNS Response, Inc. (OTCBB: CNSO) at the Special Meeting of Stockholders held...
241 - United BioSource Corporation (UBC) Announces at ICAD 2009 the Addition of Bengt Winblad, MD, PhD to Its European Scientific Advisory Board for CNS Clinical Trials
BETHESDA, Md.-(Business Wire)-September 4, 2009 - Leading Alzheimer’s Disease Researcher Will Support UBC’s Continuing Efforts to Improve Data Quality in CNS Clinical Trials Key points: UBC continues to maintain its scientific leadership in the field through its participation in the 2009...
242 - Hythiam Announces Presentation at the Rodman and Renshaw Annual Global Investment Conference
LOS ANGELES-(Business Wire)-September 3, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that Terren Peizer, Chairman and Chief Executive Officer of Hythiam, will be presenting at the Rodman and Renshaw Annual Global Investment Conference on Wednesday, September 9, 2009 at 12:30 p.m. EDT. The...
243 - Psychiatric Solutions to Present at the Thomas Weisel Partners Healthcare Conference
FRANKLIN, Tenn.-(Business Wire)-September 3, 2009 - Psychiatric Solutions, Inc. (“PSI”) (NASDAQ: PSYS) announced today it will participate in the Thomas Weisel Partners Healthcare Conference, which takes place September 9th through September 11th in Boston, Massachusetts. In connection with...
244 - Brain Training Experts Offer Advice During ADHD Awareness Month
COLORADO SPRINGS, Colo.-(Business Wire)-September 3, 2009 - September is National Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month. And, more than 60 LearningRx franchisees are showing parents how to increase the three types of attention skills. “We’re excited to share the...
245 - Tackle Your Tailgate This Football Season with Mouthwatering Dishes From FoodNetwork.com
NEW YORK-(Business Wire)-September 3, 2009 - No matter the team match-up, every football fan can rah-rah a good tailgate party come game day. Just in time for the first kickoff this season, hosts can plot out their culinary play-by-play at FoodNetwork.com, with a special recipe and video package...
246 - Leonard J. Brandt Issues Statement Regarding CNS Response, Inc.
IRVINE, Calif.-(Business Wire)-September 2, 2009 - Leonard J. Brandt today issued the following statement: The stockholders of CNS Response, Inc. (OTCBB: CNSO) have been told not to vote by CNS Response, Inc.'s incumbent Board and management. Some of the major stockholders of CNS are finding that...
247 - Alkermes’ Corporate Presentation to be Webcast at the Thomas Weisel Partners Annual Healthcare Conference
CAMBRIDGE, Mass.-(Business Wire)-September 2, 2009 - Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Wednesday, September 9, 2009, at 1:30 p.m. ET from the Four Seasons Hotel in Boston. The presentation may be accessed...
248 - Seeking Treatment is Important, Proper and Unique Care is Vital
SEYMOUR, Tenn.-(Business Wire)-September 2, 2009 - An estimated 22 million Americans suffered from substance dependence or abuse, according to Substance Abuse and Mental Health Services Administration (SAMHSA) in 2002. September is National Recovery Month and Brookhaven Retreat, a...
249 - Information for California Fire Victims and Evacuees
LOS ANGELES-(Business Wire)-September 1, 2009 - Health Net of California, Inc. is helping ensure that Health Net members who are victims and evacuees of the wildfires currently taking place in California have access to essential prescription medications, critical Health Net information and...
250 - New Advances in Traumatic Brain Injury Will Be Presented at University of New Mexico on September 4
NEW YORK-(Business Wire)-September 1, 2009 - Dr. David Durham will present Advances in Traumatic Brain Injury at the University of New Mexico on Friday, September 4th to physicians and medical students in the departments of psychiatry and neurology. A neuropsychiatrist specializing in traumatic...
251 - Applied NeuroSolutions Appoints Craig Taylor as President & CEO
VERNON HILLS, Ill.-(Business Wire)-September 1, 2009 - Applied NeuroSolutions, Inc. (OTCBB: APSN) (www.AppliedNeuroSolutions.com), a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer’s disease (“AD”), today announced the appointment...
252 - Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex
ALBUQUERQUE, N.M.-(Business Wire)-September 1, 2009 - Researchers at the Mind Research Network today announced the findings of a scientific study that used brain imaging and Tetris to investigate whether practice makes the brain efficient because it increases gray matter. Over a three-month...
253 - ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson’s Disease Psychosis
SAN DIEGO-(Business Wire)-September 1, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the first pivotal Phase III trial with pimavanserin in patients with Parkinson’s disease psychosis, or PDP. The study did not meet its primary endpoint of antipsychotic...
254 - Cannabis Science Signs Leading Points Corporation To Advance State and Federal Agencies Programs
COLORADO SPRINGS, Colo.-(Business Wire)-August 31, 2009 - Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company is pleased to announce that the company has signed an agreement with Leading Points Corporation to represent its products, services and initiatives...
255 - The GEO Group Announces Acquisition of Just Care, Inc. and Increases 2009 Earnings Guidance
BOCA RATON, Fla.-(Business Wire)-August 31, 2009 - The GEO Group (NYSE:GEO) (“GEO”), a world leader in the delivery of correctional, detention, and mental health services, announced today that its mental health subsidiary, GEO Care, Inc. (“GEO Care”), has signed a definitive agreement to...
256 - PsychoGenics and AstraZeneca Enter Agreement to Identify New Treatments for Central Nervous System Disorders
TARRYTOWN, N.Y.-(Business Wire)-August 31, 2009 - PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders. Under the agreement, PsychoGenics...
257 - eClinicalWorks Enters Partnership with Correctional Medical Services, Inc.
WESTBOROUGH, Mass.-(Business Wire)-August 31, 2009 - eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that the company has entered into an agreement with Correctional Medical Services, Inc. (CMS), a leading provider of health services for prisons and jails...
258 - Hythiam Receives NASDAQ Staff Determination
LOS ANGELES-(Business Wire)-August 28, 2009 - Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the “Company”) received a letter (the “Staff Determination”) from the Nasdaq Stock Market (“NASDAQ”) notifying the Company that, based upon the Company’s...
259 - National Quality Forum Endorses IMS Health Measures to Improve Medication Safety and Quality
NORWALK, Conn.-(Business Wire)-August 26, 2009 - IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, has received the endorsement of the National Quality Forum (NQF) for two of its clinical quality indicators for measuring...
260 - PHC Awarded Contract Worth Minimum of $1.24 Million to Provide Behavioral Health Services to Salt Lake City Veteran Administration’s Medical Center
PEABODY, Mass.-(Business Wire)-August 25, 2009 - PHC, Inc., d.b.a. Pioneer Behavioral Health (NYSE AMEX: PHC), a leading provider of inpatient and outpatient behavioral health services, announced today that it has been awarded a contract by the Salt Lake City Veteran’s Administration Medical...
261 - LabConnect Appoints Chief Operating Officer
SEATTLE-(Business Wire)-August 25, 2009 - LabConnect, LLC, today announced the appointment of Frank D. Morrow, Ph.D., FACN, as its chief operating officer. Dr. Morrow is a veteran of the central lab business, having served as founding executive, president and chief scientific officer at Quintiles...
262 - Researchers at Signature Genomic Laboratories Identify Likely Causative Gene for New Genetic Disorder
SPOKANE, Wash.-(Business Wire)-August 24, 2009 - Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained mental retardation and/or birth defects, recently identified what is likely to be the causative gene...
263 - Research and Markets: Clinical Interviewing, 4th Edition Out Now
DUBLIN, Ireland-(Business Wire)-February 17, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Clinical Interviewing, 4th Edition" to their offering. The Fourth Edition of the classic Clinical Interviewing by John and Rita Sommers-Flanagan reflects...
264 - Montana Meth Project Officials Thank State's Teens for Unprecedented Show of Support
HELENA, Mont.-(Business Wire)-February 16, 2009 - At an event at the State Capitol today, officials from the Montana Meth Project thanked the state’s teens, public officials, community leaders and volunteers for their commitment to the statewide campaign. The event was part of the March Against...
265 - With a Plan to Make History, Timberline Knolls Takes Steps to Put Eating Disorders In the Past
CHICAGO-(Business Wire)-February 16, 2009 - Timberline Knolls, a Chicago-based residential treatment center for women suffering from eating disorders, substance abuse, self-injury and other emotional disorders, will fight “Until Eating Disorders are History,” the 2009 theme for National Eating...
266 - OptumHealth Provides Free Counseling Help Line for People in Oklahoma Affected by Tornadoes
OKLAHOMA CITY-(Business Wire)-February 14, 2009 - OptumHealth Inc. announced today that it is providing a free help line to people in Oklahoma who are trying to cope with the emotional consequences of the recent tornadoes that hit the region. Staffed by experienced master’s-level behavioral health...
267 - National Mentor Holdings, Inc. To Hold First Quarter FY09 Conference Call
BOSTON-(Business Wire)-February 13, 2009 - National Mentor Holdings, Inc. today announced that it will hold a conference call on Friday, February 20, 2009 at 11 a.m. EST to discuss its financial results for the first quarter ended December 31, 2008. The call will be broadcast live on National...
268 - Research and Markets: Schema Therapy for Borderline Personality Disorder: A Treatment Model and an Array of Methods and Techniques for Treating BPD Clients
DUBLIN, Ireland-(Business Wire)-February 13, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Schema Therapy for Borderline Personality Disorder" to their offering. This book was first published in Dutch by Uitgeverij Nieuwezijds this book is an English...
269 - Allied Health Care Workforce Program Report Assesses Central California Health Minority Workforce
FRESNO, Calif.-(Business Wire)-February 12, 2009 - Some of the greatest opportunities for employment in Central California over the next decade are as dental assistants, medical assistants, home health aides and nursing assistants according to the Allied Health Regional Workforce Analysis...
270 - This Valentine’s Day, Reach out to Your Loved Ones, Not Just Your Lover
NASHVILLE, Tenn. & WASHINGTON-(Business Wire)-February 12, 2009 - Valentine’s Day, the traditional celebration of love and romance, is also a great opportunity to reach out to friends and loved ones, according to data from the Gallup-Healthways Well-Being IndexTM (WBI). Major holidays, such as...
271 - Targacept Reports Fourth Quarter and 2008 Financial Results
WINSTON-SALEM, N.C.-(Business Wire)-February 12, 2009 - Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today reported its financial results for the fourth quarter and year ended December 31, 2008. Targacept...
272 - MedeFinance and Health Integrated Partner to Give Health Plans Competitive Advantage
TAMPA, Fla. & EMERYVILLE, Calif.-(Business Wire)-February 12, 2009 - Health Integrated, the leading Targeted Population Health Management company, and MedeFinance, the leading Healthcare Performance Analytics company, are partnering to jointly offer health plan customers services that combine...
273 - Friends Hospital Shines Spotlight on National Eating Disorders Awareness Week; Offers Free Telephone Consultation to Sufferers and Their Family Members
PHILADELPHIA-(Business Wire)-February 12, 2009 - In recognition of National Eating Disorders Awareness Week (Feb. 22-28), Friends Hospital is offering free telephone eating disorder consultations from Monday, Feb. 23 to Friday, Feb. 27, between the hours of 10 a.m. and 2 p.m. Consultations are...
274 - Hythiam Announces Presentation at the Roth 21st Annual OC Growth Stock Conference
LOS ANGELES-(Business Wire)-February 12, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that Terren Peizer, Chairman and Chief Executive Officer of Hythiam, will be presenting at the Roth Capital Partners 21st Annual OC Conference on Wednesday, February 18, 2009 at 5:00 p.m. PST. The event...
275 - Signature Microarray Covers Regions of the Genome Associated with Schizophrenia
SPOKANE, Wash.-(Business Wire)-February 12, 2009 - Signature Genomic Laboratories’ flagship microarray, the SignatureChip®, covers regions of the human genome that were known and recently published to be associated with susceptibility to schizophrenia. A study led by investigators from Duke...
276 - Fitch to Assign an 'A+/F1+' Rating to New York State Dorm Auth's $156MM 2003D-2A Mental Health Revs
NEW YORK-(Business Wire)-February 11, 2009 - Fitch Ratings will assign a rating of 'A+/F1+' to the $156,000,000 Dormitory Authority of the State of New York (DASNY) mental health services facilities improvement revenue bonds, subseries 2003D-2A. The rating, which will be effective on March 2...
277 - Oklahoma Professional Counselors Searches Now Available Online at http://www.OK.gov
OKLAHOMA CITY-(Business Wire)-February 11, 2009 - Citizens wanting to confirm the legitimacy of their marital or other professional counselor can now do so quickly online. The Oklahoma State Department of Health (OSDH) recently launched a public search utility providing immediate access to all...
278 - UT Southwestern Performs First Local Implant in Deep Brain Stimulation Study for Depression
DALLAS-(Business Wire)-February 11, 2009 - UT Southwestern Medical Center neurological surgeons have begun implanting patients as part of a clinical study that is investigating whether deep brain stimulation (DBS) therapy may help people who suffer from major depressive disorder, a severe form of...
279 - Research and Markets: Essential Collection of 50 Case Studies Reveals the Essentials of Clinical Physiology and Pharmacology
DUBLIN, Ireland-(Business Wire)-February 11, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Clinical Physiology and Pharmacology: The Essentials" to their offering. This book is an accessible collection of case study scenarios ideal for physiology and...
280 - State of New Mexico Selects OptumHealth to Provide Statewide Mental Health and Substance Abuse Services
GOLDEN VALLEY, Minn.-(Business Wire)-February 10, 2009 - OptumHealth Inc. today announced it has been selected by the state of New Mexico’s Interagency Behavioral Health Purchasing Collaborative to manage several publicly funded mental health and substance abuse programs. These include the...
281 - Research and Markets: Narcolepsy - Entry-Point to a Lucrative Fatigue-Associated Market - Provigil (Modafinil), Expected To Launch In 2012
DUBLIN, Ireland-(Business Wire)-February 10, 2009 - Research and Markets views on topical issues in the current and future treatment of narcolepsy and associated disorders. Appreciate the potential of off-label prescribing and indication expansions for treatments possessing narcolepsy as the primary...
282 - Dana-Farber Cancer Institute Master Class CME Delivers Best Practices from Internationally Renowned Medical Leaders
BOSTON-(Business Wire)-February 10, 2009 - Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School, announces today its Master Class for Oncologist to meet the educational needs of the community oncologist. Sharing of knowledge and best practices equates to improved...
283 - Research and Markets: Forecast Insight: Depression - Generic Induced Brand Erosion Leads to Market Decline Forecast of Just $9.81 Billion in 2017 Down from $11.04 Billion in 2007
DUBLIN, Ireland-(Business Wire)-February 10, 2009 - Research and Markets on depression-specific brand sales Understand the country-specific impact of key events in the major depressive disorder market during the forecast period 2008 to 2017 For more information visit...
284 - Psychiatric Solutions Announces Fourth Quarter 2008 Earnings Release Date and Conference Call
FRANKLIN, Tenn.-(Business Wire)-February 9, 2009 - Psychiatric Solutions, Inc. (“PSI”) (Nasdaq: PSYS) today announced it will release its fourth quarter and year end 2008 earnings on Wednesday, February 25, 2009 after the market close. Psychiatric Solutions will conduct a conference call with...
285 - Research and Markets: The Severe and Persistent Mental Illness Treatment Planner, 2nd Edition - Available Now
DUBLIN, Ireland-(Business Wire)-February 9, 2009 - Research and Markets . Psychosis. Recreational Deficits. Self-Determination Deficits. Sexuality Concerns. Social Anxiety. Social Skills Deficits. Specific Fears and Avoidance. Suicidal Ideation. Appendix A. Bibliotherapy Suggestions. Appendix B...
286 - Research and Markets: With the Approval of New Products and Takeover of Markets for Obsolete Symptomatic Therapies, the Neuroprotection Market Value Will Rise by the Year 2013
DUBLIN, Ireland-(Business Wire)-February 9, 2009 - Research and Markets inhibitors, anti-inflammatory agents, neurotrophic factors, metal ion chelators, ion channel modulators and gene therapy. Some of the agents are old established pharmaceuticals whereas others are new biotechnology products...
287 - Research and Markets: "Neurostimulation Devices Pipeline Product and Technology Analysis Report" Will Allow You to Keep Abreast of the Very Latest Technological Developments
DUBLIN, Ireland-(Business Wire)-February 9, 2009 - Research and Markets 4.5 Precision Implantable neurostimulator 4.6 Andara Oscillating Field Stimulator system 4.6.1 Andara Oscillating Field Stimulator System Product Status 4.6.2 Andara Oscillating Field Stimulator System Product Description...
288 - JSA Health Changes the Face of Telepsychiatry with LifeSize HD Video Communications
AUSTIN, Texas-(Business Wire)-February 9, 2009 - Technology and innovative thinking are helping solve a public health crisis: the shortage of mental health care professionals and a growing need for psychological and psychiatric services. JSA Health is using LifeSize high definition video...
289 - Betty Ford Center Selects Sequest as Software Solution
LISLE, Ill.-(Business Wire)-February 6, 2009 - Sequest, a leading business solutions and software provider for the health and human services industry, announced today that it has been selected as the software and services solution for the Betty Ford Center. Sequest’s extensive expertise in...
290 - New Study in Science Uses Cogmed Working Memory Training to Reveal that Mental Activity can Impact the Brain’s Biochemistry
NAPERVILLE, Ill.-(Business Wire)-February 6, 2009 - The prestigious journal Science today published the results of a research study demonstrating for the first time that mental activity can alter the biochemistry of the human brain. Conducted by researchers from Sweden’s Karolinska Institute...
291 - Health Management Associates, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call and Webcast
NAPLES, Fla.-(Business Wire)-February 6, 2009 - Health Management Associates, Inc. (NYSE:HMA) announced today that on February 23, 2009 it will report results for its fourth quarter and year ended December 31, 2008. HMA will issue a press release after the market closes on Monday, February 23, 2009...
292 - Alzheimer’s Patients Needed for Stanford Study
STANFORD, Calif.-(Business Wire)-February 5, 2009 - A national team of scientists is trying to determine if an experimental drug, called a RAGE inhibitor, can help Alzheimer’s disease patients with memory loss and other symptoms. Researchers at the Stanford University School of Medicine are...
293 - Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009
WINSTON-SALEM, N.C.-(Business Wire)-February 5, 2009 - Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that it will report financial results for the fourth quarter and year ended December 31...
294 - CompuMed Inc.’s Exhibit at 2009 Masters of Pediatrics Conference Program Draws Attention to Cardiac Screening Programs for Children
LOS ANGELES & MIAMI-(Business Wire)-February 5, 2009 - CompuMed, Inc. (OTCBB:CMPD) (www.compumed.net) unveiled its landmark CardioGramKids™ program at the 2009 Masters of Pediatrics Conference in Miami, sponsored by the highly respected University of Miami Miller School of Medicine, Department...
295 - Research and Markets: Analyse Profiles of 134 Companies Involved in Developing Diagnostics and Therapeutics for Alzheimer's Disease Are Presented along with 101 Collaborations
DUBLIN, Ireland-(Business Wire)-February 5, 2009 - Research and Markets has announced the addition of Jain PharmaBiotech's new report "Alzheimer's Disease - New Drugs, Markets and Companies" to their offering. Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers...
296 - MEDNAX Earns 81 Cents, non-GAAP, in 2008 Fourth Quarter
FORT LAUDERDALE, Fla.-(Business Wire)-February 5, 2009 - MEDNAX, Inc. (NYSE:MD), the national medical group providing newborn, maternal-fetal, pediatric subspecialty and anesthesia physician services, today reported earnings per share of 85 cents for the 2008 fourth quarter, or 81 cents on a...
297 - Research and Markets: Severe and Persistent Mental Illness Progress Notes Planner
DUBLIN-(Business Wire)-February 5, 2009 - Research and Markets . Psychosis. Recreational Deficits. Self-Determination Deficits. Sexuality Concerns. Social Anxiety. Social Skills Deficits. Specific Fears and Avoidance. Suicidal Ideation. For more information visit...
298 - MEDNAX, Inc. Acquires Neonatal Practice
FORT LAUDERDALE, Fla.-(Business Wire)-February 4, 2009 - MEDNAX, Inc. (NYSE:MD) today announced that it has completed the acquisition of a neonatal group based in Arlington, Texas. Arlington Neonatal Intensive Care, P.A., is a two-physician practice that staffs the Level III neonatal intensive...
299 - Economic Study Estimates Meth Abuse Costs the U.S. $23.4 Billion
WASHINGTON-(Business Wire)-February 4, 2009 - A RAND Corporation study released today, “The Economic Cost of Methamphetamine Use in the United States, 2005,” estimates the national cost of Meth abuse is $23.4 billion. The study represents the first time that a comprehensive assessment of the...
300 - Research and Markets: This Report Covering the Chinese Market for Mental Illness Drugs is Available Now
DUBLIN, Ireland-(Business Wire)-February 3, 2009 - Research and Markets and long-term forecasts through to 2013 and 2018 are presented. Major producers in China are profiled. Key Topics Covered: INTRODUCTION BUSINESS ENVIRONMENT MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS MENTAL ILLNESS DRUGS...
301 - Merger Creates Largest Social Services Agency in the West for Children in Crisis
CAMPBELL, Calif. & DAVIS, Calif.-(Business Wire)-February 3, 2009 - Two of California’s most respected leaders in innovative services for children and families – EMQ Children & Family Services (EMQ) based in Campbell and FamiliesFirst, Inc. (FFI) based in Davis – announced today that...
302 - ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
SAN DIEGO-(Business Wire)-February 3, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at the...
303 - Targacept to Present at BIO CEO & Investor Conference
WINSTON-SALEM, N.C.-(Business Wire)-February 3, 2009 - Targacept, Inc. (Nasdaq: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to...
304 - Affymax to Present at BIO CEO and Investor Conference
PALO ALTO, Calif.-(Business Wire)-February 3, 2009 - Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene Morris, president and chief executive officer, will present at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009, at 2:15 p.m. ET at the Waldorf Astoria in New...
305 - Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference
HAWTHORNE, N.Y.-(Business Wire)-February 3, 2009 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming BIO CEO & Investor Conference on Monday, February 9, 2009 at 9:00 a.m. Eastern Time at the Waldorf=Astoria in New...
306 - Timberline Knolls Responds to “Jessica Simpson Bashing”
CHICAGO-(Business Wire)-February 2, 2009 - From size-zero models on the cover of Vogue to weight-loss success stories celebrated on syndicated television, there are many images in today’s society that are shaping an unrealistic and unhealthy body images for women of all ages. Recent criticism...
307 - Health Benefits of Resveratrol Featured on The CBS News Show 60 Minutes
BOCA RATON, Fla.-(Business Wire)-February 2, 2009 - Researchers proclaimed Resveratrol as the key to the fountain of youth on the CBS News show 60 Minutes this past Sunday. This remarkable key ingredient found in red wine may not only protect your heart - it may very well protect against some of the...
308 - Rexahn Pharmaceuticals, Inc. Initiates Clinical Trial of SerdaxinTM to Treat Depression
ROCKVILLE, Md.-(Business Wire)-February 2, 2009 - Rexahn Pharmaceuticals, Inc. (NYSE Alternext US: RNN), a leader in development of innovative therapeutics for life-threatening and life-debilitating diseases, announced today that it has initiated a Phase IIa clinical trial for SerdaxinTM, for the...
309 - Next Generation Underwriters Sponsors Child’s Wish
HENDERSONVILLE, Tenn.-(Business Wire)-January 30, 2009 - Next Generation Underwriters has sponsored a local child’s wish to go to Disney World and meet Pocahontas. Libby Shirley, a 4-year-old from Mt. Juliet, Tenn., suffers from Rett Syndrome. The developmental disorder leaves Libby unable to...
310 - Super Bowl Therapy…Venture Capital Style
MIAMI-(Business Wire)-January 30, 2009 - My Therapy Journal.com (www.MyTherapyJournal.com) has been selected as one of only 19 best private companies in Florida to present at the 2009 Florida Venture Capital Conference (known as the Super Bowl of Venture Capital) that will be held on February 3-4 at...
311 - ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation
CHELMSFORD, Mass.-(Business Wire)-January 30, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS) and Alsius Medical Corporation in the Central...
312 - Research and Markets: The Moving Forward After Brain Injury DVD Contains Current Best Practices In Brain Injury Rehabilitation
DUBLIN, Ireland-(Business Wire)-January 29, 2009 - Research and Markets , driving, travel, sexuality, and much, much more. For more information visit http://www.researchandmarkets.com/research/98da6c/moving_forward_aft
313 - Center for Health Value Innovation Names Influential Leaders in Value-Based Design to its Board of Strategic Advisors
ST. LOUIS-(Business Wire)-January 29, 2009 - The Center for Health Value Innovation (www.vbhealth.org), the nation’s premier organization dedicated to establishing value and producing evidence for sustainable health and financial improvement, announces Andrew Webber, president and CEO of the...
314 - TheraGenetics Announces Acquisition by Avacta Group PLC
CAMBRIDGE, Mass. & LONDON-(Business Wire)-January 29, 2009 - TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders...
315 - The California Endowment Supports the Launch of a New Foundation - Inspired by the Subject of the Upcoming Film “The Soloist”
LOS ANGELES-(Business Wire)-January 28, 2009 - The California Endowment, a private, statewide health foundation, today announced its commitment of a $95,820 grant to support start-up activities for the recently launched Nathaniel Anthony Ayers Foundation. Bearing the name of the gifted and...
316 - Alzheimer’s Association Calls for People to Speak Out Feb. 2
WATERTOWN, Mass.-(Business Wire)-January 28, 2009 - First there were 7,000 purple postcards calling for a state Alzheimer’s plan, sent continuously over the past few months to Governor Deval Patrick. He has not yet responded. Now, the Alzheimer's Association is stepping up the campaign by rallying...
317 - Research and Markets: Examine the Fundamentals of Mental Illness, Medicine and Law
DUBLIN, Ireland-(Business Wire)-January 28, 2009 - Research and Markets has announced the addition of the "Mental Illness, Medicine and Law" report to their offering. 'As new medical technologies and treatments develop with increasing momentum, the legal and ethical implications of medicine are...
318 - The Nathaniel Anthony Ayers Foundation Launches in Los Angeles to Raise Mental Illness Awareness
-(Business Wire)-January 28, 2009 - The California Endowment: WHAT: The California Endowment will present a sizable grant to the founders of The Nathaniel Anthony Ayers Foundation as it launches to support its mission to fund the arts at mental health agencies and arts organizations that serve...
319 - Sociability Traced to Particular Region of Brain by Stanford Scientists
STANFORD, Calif.-(Business Wire)-January 27, 2009 - People with a genetic condition called Williams syndrome are famously gregarious. Scientists, looking carefully at brain function in individuals with Williams syndrome, think they may know why this is so. The researchers at the Stanford...
320 - Speech Therapy Everywhere: TheraWeb Connects Therapists and Patients Online
KING OF PRUSSIA, Pa.-(Business Wire)-January 27, 2009 - From the comfort of his own home, a 12 year-old student signs onto a new web-based therapy service offered by Therapy Source and begins an interactive speech and language session with his therapist located hundreds of miles away. The service...
321 - enXco Signs Power Purchase Agreement with Carrier Clinic for Solar Array
ESCONDIDO, Calif.-(Business Wire)-January 27, 2009 - enXco, an EDF Energies Nouvelles Company, (PARIS: EEN) announced today the signing of a 25-year Power Purchase Agreement with Carrier Clinic, a not-for-profit behavioral healthcare system, located in Belle Mead, New Jersey. The agreement sets in...
322 - CIGNA’s Behavioral Health Care Centers Earn Full Accreditation from The National Committee for Quality Assurance
BLOOMFIELD, Conn.-(Business Wire)-January 27, 2009 - In real estate it’s all about location. In health care it’s all about quality. At the end of 2008, all four of CIGNA's behavioral health care centers nationwide earned “Full” accreditation from the National Committee for Quality...
323 - National Institute of Mental Health Selects BP Logix
SAN DIEGO-(Business Wire)-January 27, 2009 - BP Logix, a provider of web-based business process automation and reporting solutions, today announced that the National Institute of Mental Health (NIMH) has selected BP Logix Workflow Director as its workflow and electronic forms solution. The product...
324 - Foundation Inspired by Subject of Upcoming Film “The Soloist” Launches January 28th at The California Endowment’s Center for Healthy Communities
-(Business Wire)-January 26, 2009 - The California Endowment: WHAT: The official launch of the Nathaniel Anthony Ayers Foundation. Los Angeles Times Columnist Steve Lopez will discuss his initial meeting with Nathaniel Anthony Ayers and the friendship they developed over time which led to a...
325 - Research and Markets: Educational Review Manual in Psychiatry
DUBLIN, Ireland-(Business Wire)-January 26, 2009 - Research and Markets , Eisai, McNeil Consumer Healthcare, Merck & Co., Ortho McNeil Neurologics, Ortho Women's Health & Urology, Shire, Takeda and Wyeth. Each ERM consists of between 480 and 980 pages of text, with color and...
326 - For People Who Suffer from Eating Disorders, Successful Treatment is Not Far Away
KANSAS CITY, Mo.-(Business Wire)-January 26, 2009 - There is no doubt eating disorders rob teenagers, mostly young girls, of what should be the best years of their lives. In the United States, as many as 10 million females and 1 million males are fighting a life and death battle with anorexia or...
327 - Capella University Launches Online Master's Specialization in Addiction Counseling
MINNEAPOLIS-(Business Wire)-January 26, 2009 - To help meet the need for trained addiction counselors, Capella University (www.capella.edu), an accredited*, online university, has launched a new online master’s specialization in Addiction Counseling. Addiction counseling is one of the...
328 - Dr. Andrea Pennington Joins Logical Images to Raise National Awareness about Diagnostic Accuracy and Quality Care
ROCHESTER, N.Y.-(Business Wire)-January 26, 2009 - Logical Images, Inc., the expert source for visual diagnostic decision support technology and consumer skin health information, today announced that Dr. Andrea Pennington has joined the company as Chief Medical Officer. In this role, Dr...
329 - St. Jude Medical Announces European CE Mark Approval for Libra Deep Brain Stimulation Systems for Parkinson’s Disease
ST. PAUL, Minn.-(Business Wire)-January 26, 2009 - St. Jude Medical, Inc. (NYSE:STJ) today announced European CE Mark approval of its Libra® and LibraXP™ deep brain stimulation (DBS) systems for treating the symptoms of Parkinson's disease, a neurological disorder that progressively diminishes...
330 - Valor Healthcare Earns Accreditation from Joint Commission
WASHINGTON-(Business Wire)-January 22, 2009 - Driven by a commitment to provide safe, high quality healthcare to U.S. veterans, Valor Healthcare Inc. has been awarded the Joint Commission's Gold Seal of Approval™, officials announced today. With this important designation, Valor becomes the only...
331 - Neurologix Commences its Phase 2 Clinical Trial of Novel Gene Transfer Approach for Treatment of Parkinson’s Disease
FORT LEE, N.J.-(Business Wire)-January 21, 2009 - Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that it has initiated its Phase 2 clinical trial for the treatment of advanced...
332 - New Book Curing Chronic Pain by Robert T. Cochran, Jr. M.D. Offers Hope and Healing to Millions
NASHVILLE, Tenn.-(Business Wire)-January 20, 2009 - Chronic pain affects millions of people; one type alone, Fibromyalgia, affects 3-6% of the U.S. population. Chronic pain may also appear as migraines, arthritis, or a host of other conditions including, perhaps surprisingly, diseases such as...
333 - BodyLogicMD Commends Oprah Winfrey for Starting the Conversation About Bioidentical Hormone Therapy
BOCA RATON, Fla.-(Business Wire)-January 20, 2009 - “I was very pleased by the balanced show Oprah Winfrey did on bioidentical hormone therapy (BHRT),” says Alicia Stanton, M.D., BodyLogicMD Chief Medical Officer and hormone therapy expert, in response to Oprah’s January 15 show titled...
334 - BodyLogicMD’s Dr. Alicia Stanton Welcomes Marie Dam M.D. To Practice
MANCHESTER, Conn.-(Business Wire)-January 16, 2009 - In response to the tremendous demand from patients looking for bioidentical hormone therapy, BodyLogicMD’s Chief Medical Officer Dr. Alicia Stanton announces today the addition of Dr. Marie Dam to her New England practice. “More and more...
335 - American Well-Being, Quality of Life Plummet in the Midst of U.S. Financial Crisis
NASHVILLE, Tenn. & WASHINGTON-(Business Wire)-January 15, 2009 - The economic meltdown during the second half of 2008 fundamentally altered the well-being of millions of Americans, negatively impacting numerous aspects of life beyond job security and finances. That’s according to fresh...
336 - Research and Markets: Discover the Best Practices in Long Term Manual Available Now
DUBLIN, Ireland-(Business Wire)-January 15, 2009 - Research and Markets has announced the addition of the "Pain Management in LTC" report to their offering. The Pain Management in Long Term Care manual helps you to assess chronic pain, which may reduce the incidence of falls, behavior, depression...
337 - New Hope For A Better Night Sleep
-(Business Wire)-January 15, 2009 - The Greek word “apnea” literally means “without breath.” Sleep apnea is a common sleep disorder characterized by short pauses in breath during sleep. Each episode lasts long enough so that several breaths are missed, with such episodes occurring repeatedly...
338 - DSS, Inc. Invited to Speak at Sales Conference
JUNO BEACH, Fla.-(Business Wire)-January 14, 2009 - DSS, Inc. today announced that Jay Flejter, Vice President of Research and Development and Jeff Clarke, Consulting Engineer, were invited to speak at the Embarcadero Technologies Sales Kickoff meeting in San Francisco on January 12. According to...
339 - LifeLinks™ Unveils ADA/Liability Shield Software/Interpreter Package in Response to Growing Language Discrimination Litigation
NEW YORK-(Business Wire)-January 14, 2009 - Responding to a growing trend in U.S. legislative and judicial interpretations regarding communications related discrimination, LifeLinks™, a leading provider of video remote interpreting and American sign language video relay services, today unveiled an...
340 - Chapman University College Unveils Online Education Initiatives with Introduction of Health Risk and Crisis Communication Master’s Degree and Certification
ORANGE, Calif.-(Business Wire)-January 13, 2009 - Chapman University College will introduce a new Master of Science Degree and graduate certificate program in Health Risk and Crisis Communication (HRCC) as the school’s first completely online degree offering in the spring semester which...
341 - Elan Announces Webcast of Fourth Quarter and Full Year 2008 Financial Results
DUBLIN, IRELAND-(Business Wire)-January 12, 2009 - Elan Corporation, plc (NYSE:ELN) announced today that it will host a conference call on Tuesday, February 10, 2009 at 8:30 a.m. Eastern Standard Time (EST), 1:30 p.m. Greenwich Mean Time (GMT) with the investment community to discuss Elan’s fourth...
342 - James Hollis, Noted Jungian Scholar and Author to Present Public Program at Saybrook Graduate School
SAN FRANCISCO-(Business Wire)-January 9, 2009 - James Hollis, Ph.D., distinguished faculty at Saybrook Graduate School and noted Jungian scholar and author will give a public presentation in the Bay Area on Saturday, January 17 on “Shadow Encounters in Personal and Public Life,” a lecture that...
343 - Alkermes Announces Initiation of First Clinical Study for a Four-Week Long-Acting Injectable Formulation of Risperidone
CAMBRIDGE, Mass.-(Business Wire)-January 9, 2009 - Alkermes, Inc. (NASDAQ: ALKS) today announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), has initiated a phase 1 study of a four-week long-acting injectable formulation of risperidone...
344 - ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta Agonists for the Treatment of Parkinson’s Disease
SAN DIEGO-(Business Wire)-January 7, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has been awarded a...
345 - Psychiatric Solutions to Present at the 27th Annual J.P. Morgan Healthcare Conference
FRANKLIN, Tenn.-(Business Wire)-January 6, 2009 - Psychiatric Solutions, Inc. (“PSI”) (NASDAQ: PSYS) announced today it will participate in the 27th Annual J.P. Morgan Healthcare Conference, which takes place January 12 through January 15, 2009 in San Francisco at the Westin St. Francis Hotel...
346 - Johns Hopkins Brain Sciences Institute to Open at The Science + Technology Park at Johns Hopkins
BALTIMORE-(Business Wire)-January 6, 2009 - The Forest City-New East Baltimore Partnership (FCNEBP) announced that the Brain Sciences Institute of the Johns Hopkins University School of Medicine (BSI) will locate at 855 North Wolfe Street, in the John G. Rangos, Sr., Building, within the Science...
347 - NeuroActive Bike: America’s First and Only Mind-Body Fitness Equipment Launched at Lady of America Fitness Centers
MIAMI-(Business Wire)-January 6, 2009 - Fitness centers are entering the next lap of their evolution with the NeuroActive Bike, a new breed of exerciser that simultaneously trains the body and the brain, Stephane Bergeron, MD, president of Brain Center America (BCA), announced today. The...
348 - Acorda Therapeutics to Present at the 27th Annual JPMorgan Healthcare Conference
HAWTHORNE, N.Y.-(Business Wire)-January 6, 2009 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming JPMorgan Healthcare Conference on Monday, January 12, 2009 at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time at the...
349 - South Bend’s Legacy of Innovation Sparks Ignition Park
SOUTH BEND, Ind.-(Business Wire)-January 5, 2009 - It has been a place where the City of South Bend has mounted Indiana’s most aggressive environmental restoration effort to remove decaying buildings of its rust-belt past, where the legacy of Studebaker Corp. haunted the memories of a previous...
350 - Research and Markets: Essentials of DAS-II Assessment
DUBLIN, Ireland-(Business Wire)-January 5, 2009 - Research and Markets and he anticipates that the number of DAS-II administrations will be even higher. The DAS-II is a comprehensive, individually administered, clinical instrument for assessing the cognitive abilities that are important to...
351 - Emeritus Refinances Mortgage Debt
SEATTLE-(Business Wire)-December 30, 2008 - Emeritus Corporation (NYSE: ESC), a national provider of assisted living and related services to senior citizens, announced today that it has completed the refinancing of seven communities with Freddie Mac for $36.3 million at a fixed rate of 6.05% and a...
352 - Teva Announces Tentative Approval of Generic Seroquel® Tablets
JERUSALEM-(Business Wire)-December 23, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of AstraZeneca’s...
353 - Neurogen Corporation Announces Agreement for Sale of Its C5a Patent Estate and Related Assets for $2.25 Million and Receipt of Final Payment on $3 Million Sale of Chemical Library
BRANFORD, Conn.-(Business Wire)-December 23, 2008 - Neurogen Corporation (Nasdaq: NRGN), a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced it has entered into a definitive agreement to sell its C5a patent estate and related assets to a...
354 - MossRehab Awarded Three-year CARF Accreditations
PHILADELPHIA-(Business Wire)-December 22, 2008 - Following an in-depth, comprehensive survey and inspection of all operations, CARF announced that MossRehab (a part of Albert Einstein Healthcare Network) has been accredited for a period of three years for 15 of its programs – the most...
355 - Spring Forest Qigong Sends out Unique Holiday Greeting
EDEN PRAIRIE, Minn.-(Business Wire)-December 22, 2008 - One local company decided that this year, a holiday greeting card just wasn’t enough. Given the turbulent times, they decided to create and send a podcast with a meditation designed to help others slow down, open their hearts and reduce...
356 - Applied NeuroSolutions’ Renews Agreement with Noted Alzheimer’s Disease Researcher, Peter Davies, Ph.D.
VERNON HILLS, Ill.-(Business Wire)-December 22, 2008 - Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.AppliedNeuroSolutions.com), a Company focused on the development and commercialization of an integrated product portfolio for the treatment and diagnosis of Alzheimer’s disease (“AD”), today...
357 - Research and Markets: Brain-Based Therapy With Adults: Evidence-Based Treatment for Everyday Practice Reveal How This New Kind of Therapy Takes Into Account the Uniqueness of Each Client
DUBLIN, Ireland-(Business Wire)-December 22, 2008 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Brain-Based Therapy with Adults: Evidence-Based Treatment for Everyday Practice" to their offering. Brain-Based Therapy with Adults: Evidence-Based Treatment...
358 - Research and Markets: Evidence-Based Treatment for Everyday Practice in Brain-Based Therapy with Children and Adolescents
DUBLIN, Ireland-(Business Wire)-December 22, 2008 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Brain-Based Therapy with Children and Adolescents: Evidence-Based Treatment for Everyday Practice" to their offering. Designed for mental health...
359 - Research and Markets: Anxiety Disorders - Viable Indication for Antipsychotics Companies
DUBLIN, Ireland-(Business Wire)-December 19, 2008 - Research and Markets antagonists in the anxiety disorders pipeline have generated much interest among interviewed key opinion leaders. Datamonitor regards NK receptor antagonists as holding the greatest promise in the treatment of anxiety...
360 - Research and Markets: Psychosis, Trauma and Dissociation: Emerging Perspectives on Severe Psychopathology
DUBLIN, Ireland-(Business Wire)-December 19, 2008 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Psychosis, Trauma and Dissociation: Emerging Perspectives on Severe Psychopathology" to their offering. In the 100 years since Eugen Bleuler unveiled his...
Search Our News Using Google Search
Can't find what you want? Try using Google:
